ATE283270T1 - Condensierte pyridazine derivate,deren herstellung und verwendung - Google Patents

Condensierte pyridazine derivate,deren herstellung und verwendung

Info

Publication number
ATE283270T1
ATE283270T1 AT98917645T AT98917645T ATE283270T1 AT E283270 T1 ATE283270 T1 AT E283270T1 AT 98917645 T AT98917645 T AT 98917645T AT 98917645 T AT98917645 T AT 98917645T AT E283270 T1 ATE283270 T1 AT E283270T1
Authority
AT
Austria
Prior art keywords
substituted
group
atom
hydrogen atom
independently
Prior art date
Application number
AT98917645T
Other languages
English (en)
Inventor
Yasuhiko Kawano
Hideaki Nagaya
Michiyo Gyoten
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE283270T1 publication Critical patent/ATE283270T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98917645T 1997-04-25 1998-04-23 Condensierte pyridazine derivate,deren herstellung und verwendung ATE283270T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10991497 1997-04-25
JP4668898 1998-02-27
PCT/JP1998/001869 WO1998049167A1 (en) 1997-04-25 1998-04-23 Condensed pyridazine derivatives, their production and use

Publications (1)

Publication Number Publication Date
ATE283270T1 true ATE283270T1 (de) 2004-12-15

Family

ID=26386797

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98917645T ATE283270T1 (de) 1997-04-25 1998-04-23 Condensierte pyridazine derivate,deren herstellung und verwendung

Country Status (9)

Country Link
US (1) US6248740B1 (de)
EP (1) EP0979231B1 (de)
KR (1) KR100389192B1 (de)
CN (1) CN1248259A (de)
AT (1) ATE283270T1 (de)
AU (1) AU7079998A (de)
CA (1) CA2285264A1 (de)
DE (1) DE69827786T2 (de)
WO (1) WO1998049167A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407116B1 (en) 1997-09-16 2002-06-18 Takeda Chemical Industries, Inc. Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
AU6003099A (en) * 1998-10-06 2000-04-26 Takeda Chemical Industries Ltd. Fused pyridazine compounds, process for the preparation of the same and uses thereof
ATE256128T1 (de) 1998-10-21 2003-12-15 Takeda Chemical Industries Ltd Kondensierte pyridazinderivate, verfahren zu ihrer herstellung und ihre anwendung
CN1413112A (zh) * 1999-11-11 2003-04-23 武田药品工业株式会社 含有稠合哒嗪衍生物的滴鼻剂
FR2815031A1 (fr) * 2000-10-11 2002-04-12 Gilles Fillion Compositions et methodes pour la regulation du systeme nerveux
EP1426050A4 (de) * 2001-08-23 2005-05-25 Takeda Pharmaceutical Jnk-hemmer
AU2002357506A1 (en) * 2001-12-25 2003-07-15 Takeda Chemical Industries, Ltd. Acid-containing preparations
US7235556B2 (en) 2003-04-16 2007-06-26 Alcon, Inc. Methods of treating dry eye disorders
EP1618105A1 (de) * 2003-05-01 2006-01-25 Vernalis Research Limited Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten
DE102005042742A1 (de) * 2005-09-02 2007-03-08 Schering Ag Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
US7750000B2 (en) * 2005-09-02 2010-07-06 Bayer Schering Pharma Ag Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
EP1845098A1 (de) * 2006-03-29 2007-10-17 Ferrer Internacional, S.A. Imidazo[1,2-b]pyridazinen, deren Herstellungverfahren und ihre Verwendung als GABA Rezeptor Liganden
SI2350075T1 (sl) 2008-09-22 2014-06-30 Array Biopharma, Inc. Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
CN102264736B (zh) 2008-10-22 2013-08-14 阵列生物制药公司 作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
BR122019024201B1 (pt) 2010-05-20 2021-08-03 Array Biopharma Inc Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
CA2931804A1 (en) * 2013-11-27 2015-06-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Piperidine and piperazine derivatives and their use in treating viral infections and cancer
CN105503877A (zh) 2014-09-24 2016-04-20 和记黄埔医药(上海)有限公司 咪唑并哒嗪类化合物及其用途
TWI746426B (zh) 2014-11-16 2021-11-21 美商亞雷生物製藥股份有限公司 (S)-N-(5-((R)-2-(2,5-二氟苯基)-吡咯啶-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羥基吡咯啶-1-甲醯胺硫酸氫鹽結晶型
EP3368039A1 (de) 2015-10-26 2018-09-05 The Regents of The University of Colorado, A Body Corporate Punktmutationen bei trk-inhibitor-resistentem krebs und zugehörige verfahren
UA125025C2 (uk) 2016-04-04 2021-12-29 Локсо Онколоджі, Інк. Способи лікування дитячих ракових захворювань
UA125026C2 (uk) 2016-04-04 2021-12-29 Локсо Онколоджі, Інк. РІДКІ КОМПОЗИЦІЇ (S)-N-(5-((R)-2-(2,5-ДИФТОРФЕНІЛ)ПІРОЛІДИН-1-ІЛ)ПІРАЗОЛО[1,5-a]ПІРИМІДИН-3-ІЛ)-3-ГІДРОКСИПІРОЛІДИН-1-КАРБОКСАМІДУ
MX392604B (es) 2016-05-18 2025-03-24 Array Biopharma Inc Procesos para la preparacion de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidin-1-carboxamida y sales del mismo.
JOP20190092A1 (ar) 2016-10-26 2019-04-25 Array Biopharma Inc عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
WO2020023782A1 (en) 2018-07-27 2020-01-30 Biotheryx, Inc. Bifunctional compounds as cdk modulators
EP4143329A4 (de) 2020-04-28 2024-10-16 Anwita Biosciences, Inc. Interleukin-2-polypeptide und fusionsproteine davon sowie deren pharmazeutische zusammensetzungen und therapeutische anwendungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
PH27291A (en) 1989-01-31 1993-05-04 Takeda Chemical Industries Ltd Imidazolpyrimidazines their production and use
EP0440119A1 (de) 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazinverbindungen, ihre Herstellung und Verwendung
DE69106902T2 (de) 1990-03-01 1995-07-06 Takeda Chemical Industries Ltd Imidazopyridazine, ihre Herstellung und Verwendung.
TW211013B (de) * 1991-12-27 1993-08-11 Takeda Pharm Industry Co Ltd
LT3200B (en) 1992-03-18 1995-03-27 Takeda Chemical Industries Ltd Triazolopyridazine methodfor production thereof and use
DE69322673T2 (de) 1992-03-18 1999-05-06 Takeda Chemical Industries, Ltd., Osaka Imidazopyridazine als Antiasthmatika
EP0620224B1 (de) 1993-04-12 1998-07-15 Takeda Chemical Industries, Ltd. Triazolopyridazin-Derivate, ihre Herstellung und Verwendung
JPH0717971A (ja) * 1993-07-02 1995-01-20 Takeda Chem Ind Ltd イミダゾール誘導体、その製造法及び用途
TW304878B (de) 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd
CA2198019A1 (en) 1994-09-16 1996-03-21 Takeda Chemical Industries, Ltd. Triazolopyridazines process and intermediates for their preparation and their use as medicaments
AU4496896A (en) 1995-01-30 1996-08-21 Takeda Chemical Industries Ltd. Cephem compounds, their production and use

Also Published As

Publication number Publication date
WO1998049167A1 (en) 1998-11-05
CN1248259A (zh) 2000-03-22
DE69827786D1 (de) 2004-12-30
EP0979231A1 (de) 2000-02-16
US6248740B1 (en) 2001-06-19
DE69827786T2 (de) 2005-11-24
AU7079998A (en) 1998-11-24
KR20000049156A (ko) 2000-07-25
CA2285264A1 (en) 1998-11-05
EP0979231B1 (de) 2004-11-24
KR100389192B1 (ko) 2003-06-27

Similar Documents

Publication Publication Date Title
DE69827786D1 (de) Condensierte pyridazine derivate,deren herstellung und verwendung
ATE256128T1 (de) Kondensierte pyridazinderivate, verfahren zu ihrer herstellung und ihre anwendung
ATE416176T1 (de) Kondensierte chinolinderivate und deren anwendung
ATE15182T1 (de) Benzochinon-derivate und deren herstellung.
BR122017028096B8 (pt) composto, composição farmacêutica, e, uso do composto
HUP0204418A2 (hu) NHE-1 inhibitor hatású N-[(helyettesített öttagú, di- vagy triaza-, kétszeresen telítetlen gyűrű)-karbonil]-guanidin-származékok és alkalmazásuk
TR200002671T2 (tr) Bisiklo(2.2.1)Heptanlar ve ilgili bileşikler
BRPI0606319A2 (pt) compostos farmacêuticos
IS6138A (is) Kínólín afleiður sem latar fyrir MEK ensím
NO972666D0 (no) Anilinderivater med nitrogenmonoksyd-synteseinhiberende aktivitet
ES2105617T3 (es) Derivados de piperacina como antagonistas de 5-ht.
DE69122941D1 (de) Piperazinderivate
SE9603283D0 (sv) New compounds
CO4700298A1 (es) Derivados de 3-fenilisoquinoleina-1 (2h)-ona, su preparacion y su aplicacion en la terapeutica
ES2161828T3 (es) Derivados de piperidina y agentes antiplaquetarios que los contienen.
SE9102909D0 (sv) New use
ATE321552T1 (de) 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung
ATE464295T1 (de) Cyclische diaminverbindung mit fünfgliedriger cyclischer gruppe
ATE252580T1 (de) Azaindolizinon-derivate und agenzien zur verbesserung der kognitiver fähigkeiten,die dieselben als aktive inhaltstoffe enthalten
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
DE69523259D1 (de) Amine Derivate, ihre Herstellung und Anwendung
DE69810373D1 (de) Pyrrolidin Derivate, Anti-ulcus und Antibakterielle Arzneimittel
ATE137747T1 (de) Aminobenzolverbindungen, herstellung und verwendung
DE69918046D1 (de) Neue basische Derivate von Benz(e)isoindol-1-onen und Pyrrolo(3,4-c)chinolin-1-onen mit 5-HT3-antagonistischer Aktivität, ihre Herstellung und ihre therapeutische Verwendung
DE60106168D1 (de) Substituierte 1-aza-2-imino-heterocyclen und ihre verwendung als aktivatoren der nikotinergen acetylcholinrezeptoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties